Addition of the immunotherapy drug pembrolizumab to standard of care for patients with advanced soft tissue sarcoma of the ...

Prostate cancer treatment guidelines recommend against aggressive therapy for those with a life expectancy of less than 10 years.

Metastatic castration-resistant prostate cancer (mCRPC) is a severe form of late-stage disease where the tumor can no longer ...

A recent study led by Cedars-Sinai researchers reveals that a growing number of older men in the U.S. with intermediate or ...

They found that for men with limited life expectancies and intermediate- and high-risk cancers, conservative management was ...

Increasing percentages of some older U.S. men with intermediate-risk and high-risk prostate cancers are undergoing treatments that carry risks of side effects that can significantly reduce the quality ...

Philips announced that the FDA granted 510(k) clearance for its new detector-based spectral computed tomography (CT) ...

“We typically treat patients with a combination of surgery and radiation therapy,” she said. “Some patients also receive ...

October was Breast Cancer Awareness Month. According to the CDC, one in eight women will contract breast cancer. It is the ...

Ohio State cancer researchers and surgeons are developing and deploying cutting-edge techniques to help patients.

Radiation therapy has been used to treat cancer since the beginning of the 20th century. This type of treatment continues to be one of the most effective treatments for cancerous (malignant) and ...

Medical physicists at the Australian Radiation Protection and Nuclear Safety Agency (ARPANSA) have worked with the ...